Health Catalyst, Inc. (NASDAQ:HCAT) Receives $4.55 Consensus Target Price from Analysts

Health Catalyst, Inc. (NASDAQ:HCAT) has been assigned an average recommendation of “Hold” from the twelve research firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $4.5455.

Several analysts have issued reports on the company. KeyCorp dropped their price target on Health Catalyst from $5.00 to $4.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 8th. Weiss Ratings reissued a “sell (d-)” rating on shares of Health Catalyst in a research report on Wednesday, October 8th. Stifel Nicolaus cut their target price on Health Catalyst from $5.50 to $4.50 and set a “hold” rating on the stock in a research note on Friday, August 8th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $4.00 price target on shares of Health Catalyst in a research note on Tuesday, October 7th. Finally, Summit Redstone set a $5.00 price objective on shares of Health Catalyst in a report on Friday, August 29th.

Hedge Funds Weigh In On Health Catalyst

Several hedge funds have recently modified their holdings of HCAT. SG Americas Securities LLC increased its position in shares of Health Catalyst by 195.2% in the first quarter. SG Americas Securities LLC now owns 80,825 shares of the company’s stock valued at $366,000 after acquiring an additional 53,443 shares during the last quarter. Dynamic Advisor Solutions LLC increased its position in shares of Health Catalyst by 79.0% during the 1st quarter. Dynamic Advisor Solutions LLC now owns 45,585 shares of the company’s stock worth $206,000 after purchasing an additional 20,116 shares during the last quarter. Omnia Family Wealth LLC acquired a new position in shares of Health Catalyst during the 1st quarter worth approximately $157,000. AMH Equity Ltd bought a new stake in shares of Health Catalyst during the 1st quarter worth approximately $1,144,000. Finally, MCF Advisors LLC acquired a new stake in shares of Health Catalyst in the 1st quarter valued at approximately $113,000. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Trading Up 2.3%

Shares of NASDAQ:HCAT opened at $3.12 on Thursday. Health Catalyst has a 12 month low of $2.52 and a 12 month high of $9.24. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.44. The company’s fifty day simple moving average is $3.06 and its 200 day simple moving average is $3.59. The firm has a market cap of $219.55 million, a price-to-earnings ratio of -2.07 and a beta of 1.62.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.